Treatment with 0.05% atropine is associated with significant thickening of the retinal and choroidal structures, a study shows.
In children aged 3-12 years, low-dose atropine (SYD-101) significantly reduced myopia progression compared to placebo (0.77 D ...
With myopia affecting 1 in 3 people, eye experts are urging clinicians to act now to slow progression in patients.
Orthokeratology lenses can reduce axial elongation in children with myopia, with benefits observed for up to 3 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results